257 related articles for article (PubMed ID: 19099689)
1. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
Zhang J; Gui YH; Yang Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of plasma SDF-1 and its receptor CXCR4 in peripheral blood mononuclear cells of children with Kawasaki disease].
Zhang J; Gui YH; Yang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):283-6. PubMed ID: 16923357
[TBL] [Abstract][Full Text] [Related]
3. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
4. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
5. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
6. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
7. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease.
Yamamura K; Ihara K; Ikeda K; Nagata H; Mizuno Y; Hara T
Int J Immunogenet; 2012 Apr; 39(2):119-25. PubMed ID: 22117627
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.
Nomura I; Abe J; Noma S; Saito H; Gao B; Wheeler G; Leung DY
Pediatr Res; 2005 Jan; 57(1):49-55. PubMed ID: 15531734
[TBL] [Abstract][Full Text] [Related]
9. Expression of monocyte chemoattractant protein-1 in Kawasaki disease: the anti-inflammatory effect of gamma globulin therapy.
Asano T; Ogawa S
Scand J Immunol; 2000 Jan; 51(1):98-103. PubMed ID: 10632983
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence.
Fukazawa R; Ikegam E; Watanabe M; Hajikano M; Kamisago M; Katsube Y; Yamauchi H; Ochi M; Ogawa S
Circ J; 2007 May; 71(5):709-15. PubMed ID: 17456996
[TBL] [Abstract][Full Text] [Related]
11. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-93 may control vascular endothelial growth factor A in circulating peripheral blood mononuclear cells in acute Kawasaki disease.
Saito K; Nakaoka H; Takasaki I; Hirono K; Yamamoto S; Kinoshita K; Miyao N; Ibuki K; Ozawa S; Watanabe K; Bowles NE; Ichida F
Pediatr Res; 2016 Sep; 80(3):425-32. PubMed ID: 27089500
[TBL] [Abstract][Full Text] [Related]
13. Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment.
Terai M; Jibiki T; Harada A; Terashima Y; Yasukawa K; Tateno S; Hamada H; Oana S; Niimi H; Matsushima K
J Leukoc Biol; 1999 May; 65(5):566-72. PubMed ID: 10331483
[TBL] [Abstract][Full Text] [Related]
14. [Role of triggering receptor expressed on myeloid cells-1 in the pathogenesis of Kawasaki disease].
Zhao JM; Wang Q
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Jun; 18(6):522-6. PubMed ID: 27324541
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of peroxisome proliferator-activated receptor gamma and adiponectin predisposes Kawasaki disease patients to developing atherosclerosis.
Fukunaga H; Kishiro M; Akimoto K; Ohtsuka Y; Nagata S; Shimizu T
Pediatr Int; 2010 Oct; 52(5):795-800. PubMed ID: 20487372
[TBL] [Abstract][Full Text] [Related]
16. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.
Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T
Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
Kim HY; Lee HG; Kim DS
J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
[TBL] [Abstract][Full Text] [Related]
18. S100A12 on circulating endothelial cells surface in children with Kawasaki disease.
Fu S; Gong F; Xie C; Zhu W; Wang W; Shen H; Tang Y
Pediatr Res; 2010 Aug; 68(2):165-8. PubMed ID: 20461025
[TBL] [Abstract][Full Text] [Related]
19. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease.
Wong M; Silverman ED; Fish EN
J Rheumatol; 1997 Jun; 24(6):1179-85. PubMed ID: 9195529
[TBL] [Abstract][Full Text] [Related]
20. Urotensin 2 in Kawasaki disease pathogenesis.
Huang CY; Burns JC; Shimizu C
Pediatr Res; 2017 Dec; 82(6):1048-1055. PubMed ID: 28753597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
